Pharmafile Logo
Pharmafocus logo
Advanced Search

exjade

Showing 3 posts of 3 posts found.

glenmark

FDA approves Glenmark’s generic version of Novartis’ Exjade tablets for chronic iron overload

January 7, 2020
Manufacturing and Production, Research and Development Glenmark, exjade, generic, pharma

Indian pharma firm Glenmark has announced it has secured approval from the FDA for its oral deferasirox tablets in the …

News
Novartis image

Novartis drug to treat iron overload gets US nod

March 31, 2015
Sales and Marketing FDA, Novartis, blood, deferasirox, exjade, iron, jadenu

Novartis’ iron overload drug Jadenu has been given the green light by US regulators to treat patients with a serious …

News

Novartis treatments set for approval

November 19, 2012
Sales and Marketing Bexsaro, CHMP, Novartis, exjade

Two Novartis drugs, meningococcal vaccine Bexsero and iron chelation therapy Exjade, have been given positive opinions by the CHMP, with …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025